Study guide
3.2 Confrontation Fields & Automated Perimetry in Retina
IJCAHPO Certified Retina Technician CRT
Track your progress as you read
Finished sections get a check mark.
1 Exam Overview: Current CRT Requirements & Blueprint
Exam Overview: Current Requirements, Scope & Study Plan
2 Chapter 1: History Taking, Triage & Clinical Documentation
1.1 Comprehensive Ophthalmic & Medical History for Retina Patients 1.2 Telephone Triage, Urgent Symptoms & Emergency Scheduling 1.3 Scribing, Electronic Health Records & Retinal Billing Codes
3 Chapter 2: Visual Assessment & Low Vision Rehabilitation
2.1 Standardized Visual Acuity Testing & Optotypes 2.2 Sub-Chart Acuity Protocols: CF, HM, LP, and NLP 2.3 Low Vision Definitions, Optical Devices & Patient Counseling
4 Chapter 3: Pupil Assessment & Visual Field Testing
3.1 Pupillary Examination & Relative Afferent Pupillary Defect 3.2 Confrontation Fields & Automated Perimetry in Retina 3.3 Amsler Grid Testing & Metamorphopsia Monitoring
5 Chapter 4: Tonometry & Ocular Motility
4.1 Goldmann Applanation & Handheld Tonometry Techniques 4.2 Tonometer Disinfection, Calibration & Post-Procedure IOP Monitoring 4.3 Ocular Motility Assessment, Strabismus & Alignment Testing
6 Chapter 5: Diagnostic Ophthalmic Ultrasound
5.1 Ophthalmic B-Scan Echography for Posterior Segment Pathology 5.2 Standardized A-Scan Echography & Optical Biometry
7 Chapter 6: Slit Lamp, Electrophysiology & Supplemental Testing
6.1 Slit Lamp Biomicroscopy, Illumination & Fundus Lenses 6.2 Color Vision Assessment & Hertel Exophthalmometry 6.3 Ophthalmic Electrophysiology: ERG, VEP, and EOG
8 Chapter 7: Ophthalmic Microbiology & Infection Control
7.1 Ocular Pathogens & Routes of Disease Transmission 7.2 Clinical Asepsis, Universal Precautions & Vitreous Specimen Collection
9 Chapter 8: General Retinal Pharmacology & Therapeutics
8.1 Ocular Drug Delivery Methods & Routes of Administration 8.2 Mydriatics, Cycloplegics & Diagnostic Ophthalmic Dyes 8.3 Anesthetics, Glaucoma Agents & Prescription Verification
10 Chapter 9: Anti-VEGF Therapies, Steroids & Retinal Toxicity
9.1 Anti-VEGF Agents & Neovascular Retinal Diseases 9.2 Corticosteroids, Sustained-Release Implants & AREDS Supplements 9.3 Systemic Medication Retinal Toxicity & Plaquenil Screening
11 Chapter 10: Surgical Assisting & Intravitreal Procedures
10.1 Intravitreal Injection Protocol, Antisepsis & Complication Checks 10.2 Retinal Laser Therapy Modalities & Laser Safety Protocols 10.3 Surgical Instrument Handling, Tray Setup & Sterilization
12 Chapter 11: Patient Services, Education & Clinical Care
11.1 Patient Education, Chronic Disease Counseling & Treatment Adherence 11.2 Special Needs Accommodations, Patient Diversity & Interpersonal Skills 11.3 Ophthalmic Emergencies, First Aid & Clinical Care Coordination 11.4 Clinic Operations, Research Support, Forms & Referrals
13 Chapter 12: General Ocular Anatomy & Retinal Physiology
12.1 Ocular Anatomy, Orbit & Posterior Segment Architecture 12.2 Ten Retinal Layers, Photoreceptors & Macular Anatomy 12.3 Ocular Blood Supply, Microcirculation & Vitreoretinal Interface 12.4 Body Systems, Ocular Adnexa & Medical Terminology
14 Chapter 13: Retinal Pathology & Systemic Disease Manifestations
13.1 Age-Related Macular Degeneration & Retinal Vascular Occlusions 13.2 Diabetic Retinopathy & Systemic Diseases Affecting the Retina 13.3 Peripheral Retinal Degenerations, Tears & Detachments
15 Chapter 14: Ophthalmic Optics & Lensometry
14.1 Principles of Ophthalmic Optics & Refraction 14.2 Manual & Automated Lensometry Techniques
16 Chapter 15: Fundus Photography & Ophthalmic Angiography
15.1 Fundus Photography Techniques & Fundus Autofluorescence 15.2 Fluorescein Angiography Principles, Phases & Image Interpretation 15.3 Indocyanine Green Angiography & Angiographic Complication Management
17 Chapter 16: Optical Coherence Tomography (OCT & OCT-A)
16.1 OCT Principles, Scan Acquisition & Artifact Recognition 16.2 Structural OCT Interpretation: Retinal Fluid & Biomarkers 16.3 Optical Coherence Tomography Angiography (OCT-A) Principles & Flow
18 Chapter 17: Equipment Maintenance, Ethics & Regulatory Compliance
17.1 Equipment Maintenance, Calibration Schedules & Clinic Safety 17.2 Medical Ethics, Scope of Practice & Informed Consent 17.3 Patient Privacy, HIPAA Standards & Hazardous Waste Disposal
3.2 Confrontation Fields & Automated Perimetry in Retina
Key Takeaways Explain This Topic AI
Confrontation fields are a screening examination; normal confrontation does not exclude a small central, paracentral, or peripheral defect.
Automated field selection follows the clinical question: central grids sample macular function, while wider grids assess more peripheral or neurologic patterns.
Reliability indices are clues rather than universal pass-fail cutoffs; inspect gaze, response pattern, test duration, threshold map, and repeatability together.
The 2025 AAO hydroxychloroquine revision makes OCT and wide-pattern FAF primary; visual fields and multifocal ERG confirm uncertain or discordant findings.
A technician optimizes acquisition and flags artifacts, while the licensed clinician interprets the field with ocular findings and prior tests.
Last updated: September 2026
Confrontation Fields and Automated Perimetry
Visual-field testing asks what locations can be detected while fixation is maintained. Retina technicians need a reproducible technique and an understanding of artifacts, but should not turn an automated printout into an independent diagnosis.
Confrontation screening
Test one eye at a time with appropriate distance correction when needed. Sit at approximately eye level, ask the patient to look at the examiner's open eye or nose, and compare responses in corresponding areas of the examiner's own field. Depending on protocol, use finger counting, finger movement, or a small red target. Sample all quadrants and the horizontal and vertical meridians. Monitor fixation and repeat surprising responses.
Confrontation can reveal a dense hemianopia, quadrantanopia, altitudinal loss, or large central defect, but it is insensitive to subtle loss. Record the target, distance, eye, correction, fixation quality, and pattern observed. An abnormal screen usually calls for clinician review and, when ordered, formal perimetry.
Automated static perimetry
The perimeter presents stimuli against a controlled background and adjusts intensity to estimate differential light sensitivity in decibels. Common central programs include 10-2, 24-2, 24-2C, and 30-2. Grid names describe sampling patterns, not diagnoses. The ordered program, stimulus size, strategy, correction, pupil, and tested eye all matter.
Before testing, explain fixation, the response button, normal pauses, and why the patient should respond only when a stimulus is seen. Position the patient comfortably, enter the correct birth date and lens, patch the fellow eye, avoid lens-rim obstruction, and monitor gaze and fatigue. Trial lenses must be close enough to reduce rim artifact without touching lashes.
Reliability and artifacts
Fixation losses, false positives, false negatives, gaze tracking, response time, and technician observations help judge quality. No single percentage is a universal accept-or-reject rule across all devices, algorithms, diseases, and patients. A high false-positive pattern can create implausibly high sensitivities and an abnormally bright field; false negatives may rise in genuine advanced disease or fatigue. Lens rims, ptosis, small pupils, defocus, cataract, poor fixation, and learning effects can mimic loss.
Review raw thresholds, total deviation, pattern deviation when available, grayscale, probability plots, and repeatability. Pattern deviation adjusts for generalized depression, but it can also mislead in diffuse or advanced loss. The clinician interprets the complete study.
Choosing the grid
A 10-2 grid densely samples the central field and can support evaluation of macular disease. Wider patterns sample more eccentric retina and are often needed for peripheral, pericentral, or neurologic questions. Do not choose a grid solely from race or ethnicity; disease pattern and the clinician's order control.
Hydroxychloroquine screening update
The AAO's 2025 revision recommends spectral-domain OCT plus wide-pattern fundus autofluorescence as the primary objective screening tools. Automated fields and multifocal electroretinography are secondary or confirmatory tests. When fields are used, testing should be capable of assessing both parafoveal and pericentral patterns; a combined pattern such as 24-2C or appropriately selected central and wider grids may be used. A single noisy field must not trigger a medication decision. Repeat questionable acquisition and compare it with OCT, FAF, prior fields, and clinician assessment.
Technician workflow
Verify the order, eye, program, correction, and patient factors.
Explain and demonstrate the task without coaching toward a desired response.
Monitor fixation, lids, lens position, and fatigue.
Save the complete report and note deviations or interruptions.
Repeat only according to protocol or clinician direction.
Route urgent or unexpected findings promptly without independently diagnosing them.
Perimetry is most useful when technique is reproducible and serial tests are comparable.
Quality control and escalation
For confrontation testing, position the patient at the protocol distance, align eye level, occlude the non-tested eye without pressure, and compare the patient's field with the examiner's field. Present targets from nonseeing to seeing areas in more than one quadrant and vary timing so the patient cannot anticipate. Poor fixation, ptosis, spectacle rims, fatigue, hearing difficulty, or an examiner field defect can create a false abnormality.
Automated perimetry requires correct patient and eye, current near correction when specified, trial-lens position, pupil information, fixation setup, and the ordered strategy. Watch for lens-rim artifact, head drift, trigger-happy responses, sleepiness, and loss of fixation. Reliability indices and grayscale appearance support quality review but do not independently prove disease. Save the complete report and route unexpected defects, unreliable studies, or symptoms to the clinician. Repeat testing only when authorized; a technician does not delete an unfavorable field or substitute another strategy to make the printout look normal.